Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Development and Sensory Evaluation of Recipes Incorporated with Medicinal Plants Possessing Hypoglycemic and Hypolipidemic Properties


Affiliations
1 Department of Home Science, Kurukshetra University, Kurukshetra – 136119, India
     

   Subscribe/Renew Journal


Worldwide, diabetes mellitus and cardiovascular diseases are emerging as the most important cause of morbidity, mortality and disability. According to WHO-2, around the globe each year 16.7 and 3.2 million people die due to cardiovascular diseases and diabetes mellitus, respectively. Diabetes is often accompanied by dyslipidemia which contributes significantly to cardiovascular morbidity and mortality in diabetic patients. Oral hypoglycemic and hypolipidemic synthetic drugs are the mainstay of treatment of diabetes and dyslipidemia, respectively and although these drugs are effective they have prominent side-effects, lag behind poor patient compliance and are too expensive.
User
Notifications

Abstract Views: 278

PDF Views: 0




  • Development and Sensory Evaluation of Recipes Incorporated with Medicinal Plants Possessing Hypoglycemic and Hypolipidemic Properties

Abstract Views: 278  |  PDF Views: 0

Authors

Sonali Goel
Department of Home Science, Kurukshetra University, Kurukshetra – 136119, India
G. K. Kochar
Department of Home Science, Kurukshetra University, Kurukshetra – 136119, India
Taru Agarwal
Department of Home Science, Kurukshetra University, Kurukshetra – 136119, India

Abstract


Worldwide, diabetes mellitus and cardiovascular diseases are emerging as the most important cause of morbidity, mortality and disability. According to WHO-2, around the globe each year 16.7 and 3.2 million people die due to cardiovascular diseases and diabetes mellitus, respectively. Diabetes is often accompanied by dyslipidemia which contributes significantly to cardiovascular morbidity and mortality in diabetic patients. Oral hypoglycemic and hypolipidemic synthetic drugs are the mainstay of treatment of diabetes and dyslipidemia, respectively and although these drugs are effective they have prominent side-effects, lag behind poor patient compliance and are too expensive.